Hot Jobs Quality Assurance Compliance Manager | UK, Ireland or Romania (Hybrid) Associate Director, Biostatistics | New Jersey, United States (Hybrid) Director / Senior Director, Clinical Development Immunology | United States (Remote) Territory Sales Manager Advanced Research Technologies | Sydney, Australia (Hybrid) To see all of our latest jobs, click here
Who Might Benefit Most: GLP-1 therapy is particularly beneficial for individuals who: Struggle with obesity (BMI 30) or are overweight (BMI 27) with associated health conditions
Unlike other current weight loss medications on the market, it simultaneously activates three key hormone receptors: GLP-1 receptor GIP receptor Glucagon receptor By targeting all three, Retatrutide delivers a comprehensive approach to weight management by: Suppressing appetite and slowing digestion Enhancing metabolic activity Regulating blood sugar levels Promoting fat breakdown In comparison to other weight loss drugs like Wegovy and Ozempic ( Semaglutide ) that only target GLP-1, while other options like Zepbound and Mounjaro ( Tirzepatide ) activate both GLP-1 and GIP
Sembolic is given as a shot under the skin, once a week
The long-term trajectory: months 6, 12, and 24 Short-term results get the headlines